Immutep Limited

Immutep Limitedverified

IMMP

Price:

$0.3637

Market Cap:

$69.26M

Immutep Limited is a biotechnology enterprise focused on the exploration and advancement of medicinal candidates. The company specializes in creating immunotherapeutic solutions for treating both cancerous conditions and autoimmune disorders. Its primary investigational drug is eftilagimod alpha (referred to as efti or IMP321), a recombinant protein currently in a Phase IIb clinical trial, being assessed as a chemoimmunotherapy combination for metastatic breast cancer. Furthermore, Immutep is progressing several other programs: TACTI-002, which is undergoing Phase II clinical evaluation for head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003, in a Phase II...[Read more]

Industry

Biotechnology

IPO Date

2012-04-19

Stock Exchange

NASDAQ

Ticker

IMMP

The PE Ratio as of June 2026 (TTM) for Immutep Limited (IMMP) is -1.07

According to Immutep Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.07. This represents a change of -73.16% compared to the average of -3.99 of the last 4 quarters.

Immutep Limited (IMMP) Historical PE Ratio (quarterly & annually)

How has IMMP PE Ratio performed in the past?

The mean historical PE Ratio of Immutep Limited over the last ten years is -7.31. The current -1.07 PE Ratio has changed 1.36% with respect to the historical average. Over the past ten years (40 quarters), IMMP's PE Ratio was at its highest in in the December 2015 quarter at -0.90. The PE Ratio was at its lowest in in the December 2007 quarter at -167.38.

Quarterly (TTM)
Annual

Average

-7.31

Median

-6.80

Minimum

-11.83

Maximum

-2.62

Immutep Limited (IMMP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immutep Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 352.13%

Maximum Annual PE Ratio = -2.62

Minimum Annual Increase = -66.26%

Minimum Annual PE Ratio = -11.83

Quarterly (TTM)
Annual
YearPE RatioChange
2025-5.69-34.69%
2024-8.7134.89%
2023-6.46-9.52%
2022-7.13-31.23%
2021-10.38126.25%
2020-4.59-24.59%
2019-6.08-36.82%
2018-9.63-18.64%
2017-11.83352.13%
2016-2.62-66.26%

Immutep Limited (IMMP) Average PE Ratio

How has IMMP PE Ratio performed in the past?

The current PE Ratio of Immutep Limited (IMMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.95

5-year avg

-7.67

10-year avg

-7.31

Immutep Limited (IMMP) PE Ratio vs. Peers

How is IMMP’s PE Ratio compared to its peers?

Immutep Limited’s PE Ratio is greater than ProQR Therapeutics N.V. (-2.87), greater than Candel Therapeutics, Inc. (-9.81), greater than Allogene Therapeutics, Inc. (-2.63), greater than Capricor Therapeutics, Inc. (-12.93), greater than Editas Medicine, Inc. (-2.25), greater than Mereo BioPharma Group plc (-1.37), greater than Vanda Pharmaceuticals Inc. (-1.46), greater than Cabaletta Bio, Inc. (-1.92), greater than Achieve Life Sciences, Inc. (-5.67), greater than Entrada Therapeutics, Inc. (-1.63),

Build a custom stock screener for Immutep Limited (IMMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (IMMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Immutep Limited's PE Ratio?

How is the PE Ratio calculated for Immutep Limited (IMMP)?

What is the highest PE Ratio for Immutep Limited (IMMP)?

What is the 3-year average PE Ratio for Immutep Limited (IMMP)?

What is the 5-year average PE Ratio for Immutep Limited (IMMP)?

How does the current PE Ratio for Immutep Limited (IMMP) compare to its historical average?